EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023

Sarah E Smith-Jeffcoat, Alexandra M Mellis, Carlos G Grijalva, H Keipp Talbot, Jonathan Schmitz, Karen Lutrick, Katherine D Ellingson, Melissa S Stockwell, Son H McLaren, Huong Q Nguyen, Suchitra Rao, Edwin J Asturias und 4 weitere

MMWR. Morbidity and Mortality Weekly Report · 2024

DOI: 10.15585/mmwr.mm7316a2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MMWR. Morbidity and Mortality Weekly Report, 2024. Verfasst von Sarah E Smith-Jeffcoat und 15 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, SARS-CoV-2, COVID-19 Serological Testing, Virus Shedding. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As population immunity to SARS-CoV-2 evolves and new variants emerge, the role and accuracy of antigen tests remain active questions. To describe recent test performance, the detection of SARS-CoV-2 by antigen testing was compared with that by reverse transcription-polymerase chain reaction (RT-PCR) and viral culture testing during November 2022-May 2023. Participants who were enrolled in a household transmission study completed daily symptom diaries and collected two nasal swabs (tested for SARS-CoV-2 via RT-PCR, culture, and antigen tests) each day for 10 days after enrollment. Among participants with SARS-CoV-2 infection, the percentages of positive antigen, RT-PCR, and culture results were calculated each day from the onset of symptoms or, in asymptomatic persons, from the date of the first positive test result. Antigen test sensitivity was calculated using RT-PCR and viral culture as references. The peak percentage of positive antigen (59.0%) and RT-PCR (83.0%) results occurred 3 days after onset, and the peak percentage of positive culture results (52%) occurred 2 days after onset. The sensitivity of antigen tests was 47% (95% CI = 44%-50%) and 80% (95% CI = 76%-85%) using RT-PCR and culture, respectively, as references. Clinicians should be aware of the lower sensitivity of antigen testing compared with RT-PCR, which might lead to false-negative results. This finding has implications for timely initiation of SARS-CoV-2 antiviral treatment, when early diagnosis is essential; clinicians should consider RT-PCR for persons for whom antiviral treatment is recommended. Persons in the community who are at high risk for severe COVID-19 illness and eligible for antiviral treatment should seek testing from health care providers with the goal of obtaining a more sensitive diagnostic test than antigen tests (i.e., an RT-PCR test).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19SARS-CoV-2COVID-19 Serological TestingVirus SheddingAntigens, ViralHumansAdultMaleSensitivity and SpecificityFemaleMiddle AgedCOVID-19 Nucleic Acid TestingYoung AdultAdolescentUnited StatesAgedCOVID-19 Testing

Substanzen

Antigens, Viral

Förderung

  • NIAID NIH HHS

Zitieren

APA

Smith-Jeffcoat, S. E., Mellis, A. M., Grijalva, C. G., Talbot, H. K., Schmitz, J., Lutrick, K., Ellingson, K. D., Stockwell, M. S., McLaren, S. H., Nguyen, H. Q., Rao, S., Asturias, E. J., Davis-Gardner, M. E., Suthar, M. S., Kirking, H. L., & RVTN-Sentinel Study Group (2024). SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report. https://doi.org/10.15585/mmwr.mm7316a2

Vancouver

Smith-Jeffcoat SE, Mellis AM, Grijalva CG, Talbot HK, Schmitz J, Lutrick K, et al. SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023. MMWR. Morbidity and Mortality Weekly Report. 2024. doi:10.15585/mmwr.mm7316a2

BibTeX
@article{SmithJeffcoat2024,
  author = {Smith-Jeffcoat, Sarah E and Mellis, Alexandra M and Grijalva, Carlos G and Talbot, H Keipp and Schmitz, Jonathan and Lutrick, Karen and Ellingson, Katherine D and Stockwell, Melissa S and McLaren, Son H and Nguyen, Huong Q and Rao, Suchitra and Asturias, Edwin J and Davis-Gardner, Meredith E and Suthar, Mehul S and Kirking, Hannah L and RVTN-Sentinel Study Group, RVTN-Sentinel Study Group},
  title = {SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance — Respiratory Virus Transmission Network, November 2022–May 2023},
  journal = {MMWR. Morbidity and Mortality Weekly Report},
  year = {2024},
  doi = {10.15585/mmwr.mm7316a2}
}
Kostenlos starten →